Skip to main content
Caplight Logo









CLOVERNA Inc.

CLOVERNA Inc.

Private
KurashikiHealthcare & Life Scienceshttps://www.cloverna.com/

Last Round

Pre Seed

Jun 30, 2022

Total Funding Raised

$734,000

Company Overview

CLOVERNA Inc. is a biotechnology company that develops RNA-targeted drug discovery technology to identify therapeutic targets for rare and intractable diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Non-AI

Keywords

RNA-targeted drug discoverynon-coding RNAncRNARNA drug discoveryCRISPR/dCas13selective RNA-interaction modifierSRiMbiotech startupdrug discovery platformrare disease therapeuticsRNA therapeuticsintractable diseaseRNA medicinedrug discovery pipelinebiotech partnershipundruggable targets

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CLOVERNA Inc. Comparables

Compare CLOVERNA Inc. with similar companies based on industry and business-model similarity.

CLOVERNA Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Reborna Biosciences, Inc.
83%
ReviR Therapeutics
79%
HAYA Therapeutics
78%

CLOVERNA Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedJun 30, 2022

Key People

Founding team and executive leadership

Josh Onishi

CEO & Managing Director

Executive Team

CLOVERNA Inc. Investors

Notable investors and investment history

CLOVERNA Inc. investors
InvestorRounds
Keio Innovation InitiativePre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 17, 2026

    Monthly visitors increased 114% MoM.

  • Mar 2, 2026

    Monthly visitors grew 265% MoM, reaching 1.2K.

CLOVERNA Inc. Filings

Explore SEC and related filing metadata, where available.

CLOVERNA Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about CLOVERNA Inc.'s valuation, stock price, and market status.

Is CLOVERNA Inc. a public or private company?

CLOVERNA Inc. is a private company.

What is the current stock price of CLOVERNA Inc.?

CLOVERNA Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is CLOVERNA Inc. worth (valuation)?

Valuation information for CLOVERNA Inc. is not publicly available.

Can I buy CLOVERNA Inc. stock?

CLOVERNA Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was CLOVERNA Inc.'s last funding round?

CLOVERNA Inc.'s most recent funding round was Pre Seed on June 30, 2022.

Who are the main investors in CLOVERNA Inc.?

Key investors in CLOVERNA Inc. include Keio Innovation Initiative.

Will CLOVERNA Inc. IPO soon?

No public IPO plans have been announced for CLOVERNA Inc..

How can I track CLOVERNA Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CLOVERNA Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersKurashiki
Employee Range2
Year Founded2020
Last FundingJun 30, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?